欢迎进入山西医科大学公共卫生学院
卫飞雪
卫飞雪
博士，校聘教授，博士生导师
太原是新建南路56号山西医科大学公共卫生学院
山西，中国，030001
E-mail：feixuewei@outlook.com; weifeixue@sxmu.edu.cn
个人科研情况的总体描述
主要从事传染病和肿瘤流行病学研究，以人乳头瘤病毒（HPV）和宫颈癌为主要研究方向，开展中国男女性HPV感染队列研究、全球宫颈癌归因于HPV的危险性研究、全球肛门HPV感染汇总分析等研究，阐明不同人群HPV感染及自然史等重要科学问题。主持国家自然科学基金青年项目和国家科技重大专项青年项目。共发表SCI论文22篇，其中以第一作者在Lancet、Lancet HIV、Clinical Infectious Diseases、Emerging Infectious Diseases、International Journal of Cancer等医学期刊上发表SCI论文11篇。
教育经历
2008.09–2013.06.山西医科大学，医学学士，预防医学
2013.09–2019.06厦门大学，硕博连读，流行病学
研究工作经历
2019.07–2019.10世界卫生组织（WHO，瑞士日内瓦），实习生
2019.11–2023.06国际癌症研究中心（IARC/WHO，法国里昂），博士后
2023.07至今 山西医科大学/公共卫生学院，教师
学术任职
China CDC Weekly青年编委
研究方向
传染病流行病学和肿瘤流行病学
近期代表性论著
1)Wei F,Georgos D, Man I, et al. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature.The Lancet.2024, 404: 435-444.
2)Wei F,Gaisa MM, D’Souza G, et al. Epidemiology of anal human papillomavirus infection andhigh-grade lesions in 29,900 men, according to HIV status, sexuality, and age: a collaborativepooled analysisof64 studies.TheLancetHIV. 2021,8:e531-e543.
3)WeiF,GoodmanMT,XiaN,etal.Incidenceandclearanceofanalhumanpapillomavirusinfectionin 16,600 individuals, according to HIV status, gender, and male sexuality: a collaborative pooledanalysisof34longitudinalstudies.ClinInfect Dis.2023.
4)Wei F,Alberts, CJ, Albuquerque, A., & Clifford, GM. Impact of human papillomavirus vaccine against anal human papillomavirus infection, anal intraepithelial neoplasia, and recurrence of anal intraepithelial neoplasia: a systematic review and meta-analysis.J Infect Dis.2023.
5)Wei F, Guo M, Wu T, et al. Sex differences in the incidence and clearance of anogenital humanpapillomavirusinfectioninLiuzhou, China: anobservationalcohortstudy.ClinInfectDis.2020;70(1):82-89.
6)WeiF,SuY,CuiX,etal.Sequentialacquisitionofhumanpapillomavirusinfectionatgenitaland analsites,Liuzhou,China.EmergInfectDis.2020,26(10):2387-2393.
7)WeiF,ShengW,WuX,etal.IncidenceofanogenitalwartsinLiuzhou,southChina:acomparisonofdatafromaprospectivestudyandfromthenationalsurveillancesystem.EmergMicrobesInfect.2017;6(12):e113.
8)WeiF,YinK,WuX,etal.Humanpapillomavirusprevalenceandassociatedfactorsinwomenand men insouth China: a population-basedstudy.EmergMicrobes Infect. 2016, 5(11): e119.
9)Wei F,Xia N, Ocampo R, et al. Age-specific prevalence of anal and cervical HPV infection andhigh-gradelesionsin11,177womenbyHIVstatus:acollaborativepooledanalysisof26studies.JInfectDis.2022.
10)Wei F, Su Y, Yao X, et al. Sex differences in the incidence and clearance of anal humanpapillomavirusinfectionamongheterosexualmenandwomeninLiuzhou,China:Anobservationalcohort study.Int J Cancer. 2019; 145(3):807-816.
11)WeiF,LiM,WuX,etal.Theprevalenceandconcordanceofhumanpapillomavirusinfectionin differentanogenitalsitesamongmenandwomeninLiuzhou,China:Apopulation-basedstudy.IntJCancer.2018;142(6):1244-1251.
12)Lin C, Slama J, Gonzalez P, Goodman M, Xia N, Kreimer A, Wu T, Hessol N, Shvetsov Y, OrtizA, Grinsztejn B, Moscicki A, Heard I, Losa M, Kojic E, Loeff M,Wei F, et al. Cervical screeningresults and anal cancer risk: a collaborative pooled analysis of cervical determinants of anal HPVinfection and highgrade lesions in 13 427 women, according to HIV status.Lancet Infect Dis.2019;19(8):880-891.
13)Huang Y, Wnag H, Li T, Tang J, Yu H, Guo X, Song Q,Wei F, et al. Comparison of differentdetectionstrategiesforscreeningandconfirmingcongenitalcytomegalovirusinfectioninnewbornsinpopulationwithhighseroprevalence:amother-childcohortstudy.TheLancetRegionalHealth-WesternPacific.2021,12.
